论文部分内容阅读
96名慢性乙型肝炎患者,随机抽样分为马洛替酯治疗组(下称洽疗组)和对照组。治疗组采用国产马洛替酯每日1200mg,分三次口服,12周为一个疗程。对照组仅用能量合剂及维生素类药物。两组均不用输新鲜血及人体白蛋白、不使用抗毒药、护肝药和激素。观察发现治疗组治疗后总蛋白、白蛋白均极显著地提高,总胆红质明显下降,临床症状改善;而对照组治疗后血清总蛋白、白蛋白无改变。
96 patients with chronic hepatitis B were randomly divided into two groups: untreated group (control group) and control group. The treatment group with domestic Maloti ester daily 1200mg, three times orally, 12 weeks for a course of treatment. Control group only with energy mixture and vitamin drugs. No need to lose new blood and human albumin in both groups, do not use antitoxic drugs, liver drugs and hormones. After treatment, the total protein and albumin in the treatment group were significantly increased, the total bilirubin was significantly decreased, and the clinical symptoms were improved. However, the serum total protein and albumin in the control group were not changed after treatment.